Achillion Pharmaceuticals

INVESTORS

SEC Filings

 
SEC Filings
Date Filing Description View
Apr 17, 2017 DEF 14A definitive proxy statement HTML PDF XLS
603.2 KB
Feb 23, 2017 8-K current report HTML PDF XLS
218.6 KB
Feb 23, 2017 10-K annual report HTML PDF XLS XBRL
942.2 KB
Feb 23, 2017 S-3 registration statement HTML PDF XLS
386.7 KB
Feb 15, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
137.3 KB
Feb 14, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
129.4 KB
Feb 14, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
146.2 KB
Feb 13, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
126.6 KB
Feb 9, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
100.4 KB
Jan 26, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
110.1 KB
1
...
NextLast